Application form: nose preparations (drops, sprays, ointments, creams, gels)
Indication group: otorhinolaryngologicals
Active substance: Xylometazolini hydrochloridum 1 mg v 1 ml
minimum amount for dispatch: Otrivin is intended for application into the nose, where it reduces congestion of the nasal mucosal and of adjacent pharyngeal areas. Otrivin quickly relieves a blocked nose and has a long-term effect. Adjuvant substances hydroxypropyl methyl cellulose and sorbit moisturise nasal mucosa, prevent its drying and irritation.
Manufacturer: GlaxoSmithKline Consumer Healthcare GmbH & Co. KG, Germany
|SUKL název||OTRIVIN 1MG/ML NAS SPR SOL 1X10ML|